THC Therapeutics Inc
THC Therapeutics, Inc. operates in the wellness industry. It develops dHydronator, a sanitizing herb/cannabis dryer. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was founded in 2007 and is based in Jacksboro, Texas.
THC Therapeutics Inc (THCT) - Total Assets
Latest total assets as of October 2024: $11.81K USD
Based on the latest financial reports, THC Therapeutics Inc (THCT) holds total assets worth $11.81K USD as of October 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
THC Therapeutics Inc - Total Assets Trend (2007–2024)
This chart illustrates how THC Therapeutics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
THC Therapeutics Inc - Asset Composition Analysis
Current Asset Composition (July 2024)
THC Therapeutics Inc's total assets of $11.81K consist of 7.5% current assets and 92.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $12.01K | 92.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how THC Therapeutics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: THC Therapeutics Inc's current assets represent 7.5% of total assets in 2024, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2024, down from 100.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 92.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 92.5% of total assets.
THC Therapeutics Inc Competitors by Total Assets
Key competitors of THC Therapeutics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
THC Therapeutics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - THC Therapeutics Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - THC Therapeutics Inc is currently not profitable relative to its asset base.
THC Therapeutics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.00 | 0.02 |
| Quick Ratio | 0.00 | 0.00 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.43 Million | $ -3.19 Million | $ -1.82 Million |
THC Therapeutics Inc - Advanced Valuation Insights
This section examines the relationship between THC Therapeutics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 46.07 |
| Latest Market Cap to Assets Ratio | 0.69 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $12.99K |
| Market Capitalization | $8.92K USD |
Valuation Analysis
Below Book Valuation: The market values THC Therapeutics Inc's assets below their book value (0.69 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: THC Therapeutics Inc's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for THC Therapeutics Inc (2007–2024)
The table below shows the annual total assets of THC Therapeutics Inc from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-07-31 | $12.99K | 0.00% |
| 2023-07-31 | $12.99K | -93.72% |
| 2022-07-31 | $206.90K | -56.90% |
| 2021-07-31 | $480.07K | +462.50% |
| 2020-07-31 | $85.35K | -83.59% |
| 2019-07-31 | $520.02K | -79.36% |
| 2018-07-31 | $2.52 Million | -51.17% |
| 2017-07-31 | $5.16 Million | +2835.09% |
| 2016-07-31 | $175.78K | -3.39% |
| 2015-07-31 | $181.95K | +0.32% |
| 2014-07-31 | $181.37K | -6.02% |
| 2013-07-31 | $193.00K | -67.58% |
| 2012-07-31 | $595.39K | +5321.04% |
| 2010-07-31 | $10.98K | +570.51% |
| 2009-07-31 | $1.64K | -81.95% |
| 2008-07-31 | $9.07K | -46.84% |
| 2007-07-31 | $17.07K | -- |